- 2023, Volume 81 - Number 2
- Published: June 27, 2023
Vaccination in the setting of sexually transmitted infections consultation
Lanyu Sun 1, Cláudia Brazão 2, Dora Mancha 3, Diogo de Sousa 4, João Borges-da-Costa 5
1 Serviço de Dermatologia, Unidade Local de Saúde Santa Maria, Lisbon, Portugal; 2 Serviço de Dermatologia, ULS Santa Maria. Portugal; 3 Department of Dermatology, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal; Dermatology University Clinic, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal; 4 Dermatology and Venereology Department, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal; Dermatology and Venereology University Clinic, Faculty of Medicine, University of Lisbon, Lisbon, Portugal; 5 Preventive Medicine, Dermatology and Venereology, Faculty of Medicine, University of Lisbon, Lisbon, Portugal
Lanyu Sun, Cláudia Brazão, Dora Mancha, Diogo de Sousa, João Borges-da-Costa
La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.
*Correspondence: Cláudia Brazão, Email not available
Abstract
Sexually transmitted infections (STIs) are a significant public health concern across the globe. Vaccines have played a crucial role in mitigating the burden of infectious diseases and are the most effective candidates for preventing STIs. Currently, vaccines for hepatitis A, hepatitis B virus (HBV), and human papillomavirus (HPV) are available. More recently, the smallpox vaccine was approved for Mpox (MPX) prevention. Ongoing research efforts are focused on developing vaccines for other STIs. This paper reviews the current indications for available vaccines for use in the context of STIs and discusses some of the vaccines currently being researched.
